Zhejiang Medicine Co Ltd (600216) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥690.77 Million ≈ $101.08 Million USD) by net assets (CN¥11.21 Billion ≈ $1.64 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600216 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Zhejiang Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Zhejiang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MicroPort Scientific Corporation
F:MSK
-0.055x
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
0.100x
Shenzhen Zhenye Group Co Ltd
SHE:000006
-0.037x
Alembic Pharmaceuticals Limited
NSE:APLLTD
0.076x
Petrovietnam Power Corp
VN:POW
-0.080x
Fujian Snowman Co Ltd
SHE:002639
-0.035x
Siltronic AG
XETRA:WAF
0.027x
Shenzhen Rayitek Hi-Tech Film Co. Ltd. A
SHG:688323
0.017x

Annual Cash Flow Conversion Efficiency for Zhejiang Medicine Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Medicine Co Ltd (600216) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥11.09 Billion
≈ $1.62 Billion
CN¥1.89 Billion
≈ $275.95 Million
0.170x +51.08%
2024-12-31 CN¥10.87 Billion
≈ $1.59 Billion
CN¥1.22 Billion
≈ $179.01 Million
0.113x +77.21%
2023-12-31 CN¥9.99 Billion
≈ $1.46 Billion
CN¥634.31 Million
≈ $92.82 Million
0.064x +18.47%
2022-12-31 CN¥9.71 Billion
≈ $1.42 Billion
CN¥520.60 Million
≈ $76.18 Million
0.054x -56.69%
2021-12-31 CN¥9.18 Billion
≈ $1.34 Billion
CN¥1.14 Billion
≈ $166.33 Million
0.124x -20.90%
2020-12-31 CN¥8.03 Billion
≈ $1.18 Billion
CN¥1.26 Billion
≈ $183.90 Million
0.157x +188.76%
2019-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥447.25 Million
≈ $65.45 Million
0.054x -24.45%
2018-12-31 CN¥8.08 Billion
≈ $1.18 Billion
CN¥579.91 Million
≈ $84.86 Million
0.072x +10.84%
2017-12-31 CN¥7.78 Billion
≈ $1.14 Billion
CN¥503.47 Million
≈ $73.67 Million
0.065x +34.62%
2016-12-31 CN¥6.99 Billion
≈ $1.02 Billion
CN¥336.14 Million
≈ $49.19 Million
0.048x +198.51%
2015-12-31 CN¥6.62 Billion
≈ $968.00 Million
CN¥106.54 Million
≈ $15.59 Million
0.016x -80.78%
2014-12-31 CN¥6.56 Billion
≈ $960.18 Million
CN¥549.90 Million
≈ $80.47 Million
0.084x -17.10%
2013-12-31 CN¥6.48 Billion
≈ $948.29 Million
CN¥655.09 Million
≈ $95.86 Million
0.101x -22.42%
2012-12-31 CN¥6.20 Billion
≈ $906.81 Million
CN¥807.49 Million
≈ $118.16 Million
0.130x -37.18%
2011-12-31 CN¥4.40 Billion
≈ $643.92 Million
CN¥912.75 Million
≈ $133.56 Million
0.207x -39.12%
2010-12-31 CN¥3.86 Billion
≈ $565.33 Million
CN¥1.32 Billion
≈ $192.62 Million
0.341x -33.46%
2009-12-31 CN¥2.86 Billion
≈ $418.70 Million
CN¥1.47 Billion
≈ $214.39 Million
0.512x -22.67%
2008-12-31 CN¥1.81 Billion
≈ $265.19 Million
CN¥1.20 Billion
≈ $175.59 Million
0.662x +154.11%
2007-12-31 CN¥873.73 Million
≈ $127.85 Million
CN¥227.67 Million
≈ $33.32 Million
0.261x +19.49%
2006-12-31 CN¥777.31 Million
≈ $113.74 Million
CN¥169.51 Million
≈ $24.80 Million
0.218x +535.06%
2005-12-31 CN¥732.23 Million
≈ $107.15 Million
CN¥25.14 Million
≈ $3.68 Million
0.034x -79.39%
2004-12-31 CN¥645.68 Million
≈ $94.48 Million
CN¥107.60 Million
≈ $15.75 Million
0.167x +58.20%
2003-12-31 CN¥628.48 Million
≈ $91.97 Million
CN¥66.20 Million
≈ $9.69 Million
0.105x +186.82%
2002-12-31 CN¥629.71 Million
≈ $92.15 Million
CN¥23.13 Million
≈ $3.38 Million
0.037x -77.25%
2001-12-31 CN¥608.50 Million
≈ $89.04 Million
CN¥98.25 Million
≈ $14.38 Million
0.161x +868.83%
2000-12-31 CN¥635.03 Million
≈ $92.92 Million
CN¥10.58 Million
≈ $1.55 Million
0.017x +120.07%
1999-12-31 CN¥625.07 Million
≈ $91.47 Million
CN¥-51.90 Million
≈ $-7.60 Million
-0.083x -150.15%
1998-12-31 CN¥348.61 Million
≈ $51.01 Million
CN¥57.72 Million
≈ $8.45 Million
0.166x --

About Zhejiang Medicine Co Ltd

SHG:600216 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.62 Billion
CN¥11.08 Billion CNY
Market Cap Rank
#7065 Global
#1607 in China
Share Price
CN¥11.52
Change (1 day)
-2.12%
52-Week Range
CN¥11.52 - CN¥18.38
All Time High
CN¥20.16
About

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition produ… Read more